BioVox

With a local focus and global reach, the news platform BioVox shares insights into the Benelux life sciences ecosystem with readers across the world. BioVox is an independent publisher, providing its community with quality content and first-row access to interesting breakthroughs and trends in biotech, medtech, agtech, pharma, and more. We shine a spotlight on the latest news and innovations from both our partners and community.

BioVox

September 12, 2016

Fluidda: fresh air in the respiratory field

for BioVox

Interdisciplinary work and discussion can yield remarkable results. Fluidda has combined aerospace engineering and biomedical expertise to create a truly unique profile. [...]

September 12, 2016

Biotech financials: Part 1 – The bigger the company, the bigger the money

for BioVox

September 12, 2016

Lifting life sciences to the next level: a cross-disciplinary game

for BioVox

September 12, 2016

The PhD of Sue Ellen : Start small to dream big

for BioVox

September 7, 2016

Confo Therapeutics appoints Dr. Cedric Ververken as Chief Executive Officer

for BioVox

From October 1st onwards, Confo Therapeutics will be led by their new CEO Dr. Cedric Ververken. Ververken joins Confo Therapeutics from Ablynx, where he most recently acted as Vice President Business Development, heading the company’s partnering activities around specific products and Nanobody drug discovery collaborations with top tier pharmaceutical companies. With the appointment of the new CEO, the company is aiming to transform Confo Therapeutics into a drug discovery and development company.